Do you know our newsletter? Sign up (below in the footer) to get the latest on sales, new releases and more.
On 28 March 2023, the ISO 1385 certificate of myPOLS Biotec was confirmed during the annual surveillance audit. A great achievement for the team!
ISO 13485 Certificate: Download in English
ISO 13485 Certificate: Download in German
Read the full press release: Link to www.medixbiochemica.com
Engineered DNA and RNA polymerases underpin several biochemical techniques, particularly molecular diagnostics (MDx), with the potential to help to reduce assay development complexity and further shorten the time needed for the development of market-ready molecular diagnostics kits.
Join Dr. Kevin Eboigbodin, our Senior Director of Molecular Diagnostic Reagents, and Prof. Andreas Marx, Professor of Organic Chemistry at the University of Konstanz, as they share the latest developments in polymerase engineering.
When: Friday 24 June, at 13:00 BST / 14:00 CEST / 08:00 EDT / 05:00 PDT
Register here: Link to SelectScience
Looking for the recorded webinar? Click here to view on demand
Missed the live Select Science webinar with Dr Kevin Eboigbodin and Professor Andreas Marx on the future of engineered polymerases?
Watch the full webinar, watch bite size videos or listen to the podcast. Supporting your educational needs – we IVDo that!
Watch the full webinar, bite size videos or listen to the podcast.
We are proud to announce that we are joining Medix Biochemica Group, a leading global supplier of critical raw materials to the in vitro diagnostics (IVD) industry. Through this partnership, myPOLS Biotec becomes a part of Medix Biochemica’s Molecular Diagnostics Business Unit.
Our operations in Konstanz continue as usual and will form a significant part of Medix Biochemica. All founders of myPOLS Biotec will also remain involved in the business.
We are very pleased that Dr. Ramon Kranaster - co-founder and managing director of myPOLS Biotec GmbH - will be giving the keynote lecture "Science in the Pandemic: Who had heard of PCR before Corona?" on 27 October 2021.
Wednesday, 27 October 2021, 10 a.m.
Audimax (invited guests)
Online broadcast (uni.kn/diesacademicus)
The newly developed freeze-dried qPCR kit enables Legionella Detection in 2 hours.
All-in one and ready-to use by freeze-drying
The aim of the project was to develop an assay containing all the necessary components for multiplex qPCR. The brand-new Bio Lp-1 is an all-in-one kit and ready-to-use including all sample preparation steps. All multiplex PCR components are freeze-dried and allow the start of PCR process with a minimum of one pipetting step per sample. Requiring storage at ambient temperature only, thus negating the need for polystyrene-boxes and cold chain logistics, the entire kit can be shipped in an environmentally friendly way.
myPOLS Biotec has been developing and producing standard and customized freeze-dried reagents for PCR since 2015. And was therefore the partner of choice for this project.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 950822.
On 13 April 2021, the ISO 1385 certificate of myPOLS Biotec was confirmed during the annual surveillance audit. A great achievement for the team!
ISO 13485 Certificate: Download in English
ISO 13485 Certificate: Download in German
Great News: Our Volcano3G® products support accelerated SARS-CoV-2 detection
Fraunhofer IMM run these tests with our Volcano3G® products. Read the full press release from Fraunhofer IMM here: https://www.imm.fraunhofer.de/en/press-publications/qpcr-15min.html
Want to know more about the Volcano3G® product family?
myPOLS Biotec GmbH launches its successful SARS-CoV-2 detection kit in a CE-IVD validated variant: Volcano3G® Direct COVID-19 Kit IVD. The special feature: the CE-compliant validation is established for RT-PCR directly from “gargle” (pharyngeal lavage) samples.
Kit IVD stands out from other products on the market primarily due to three features:
In addition, the RT-PCR test is very cost-effective: the CE-IVD variant can be ordered for 490 Euro/100 reactions. The variant for general laboratory use (RUO) costs 390 Euro/100 reactions. Discounts are available for bulk orders. Both can be ordered directly from our online store.
Hyperstone GmbH from Constance takes care of Corona prevention in the company and offers its employees voluntary PCR tests twice a week - free of charge. This testing is made possible by the SARS-CoV-2 monitoring service of myPOLS Biotec Gmbh.
The Johner Institute and myPOLS Biotec GmbH are creating a cooperation and working together on quality-tested reagent products. These products can be applied as component in your IVD in order to contribute to safe and efficient test results. Reagent development and production meet the relevant requirements of the EU In Vitro Diagnostics Regulation (IVDR), which the cooperation partners express with the "Diagnosticgrade" seal.
For your IVDR compliant products you will receive from us:
Konstanz, 19. Februar 2021
Due to the successful SARS-CoV-2 screening at the University of Konstanz, myPOLS Biotec has compiled an information sheet describing this screening. We would like to contribute to the implementation of this successful model at other universities and offer our support.
The kit is based on a research cooperation with the University of Konstanz. This cooperation developed a new rapid Covid-19 detection process accelerating SARS-CoV-2 detection by skipping RNA extraction (see News below). This process, is based on an innovative DNA polymerase, developed and produced by myPOLS Biotec.
myPOLS Biotec has now decided to offer the new process in a Direct SARS-CoV-2 RT-PCR detection kit w/o RNA extraction. The kit contains an in-house developed master mix and a duplex primer/probe mix for both SARS-CoV-2 (N1 gene specific) and RNaseP control. It´s for research use only.
News published November 23, 2020
The study in collaboration with the local University of Konstanz, research group of Prof. Hauck, has now been published in PLOS ONE: Detection of SARS-CoV-2 from raw patient samples by coupled high temperature reverse transcription and amplification
News published November 03, 2020
We almost reach the end of 2020. Maybe you already plan for 2021 and want to fill up your stock? Use our special End-of-Year Offer: get 15% discount for our master mixes and polymerases! We deliver in 2020 or 2021, depending on your needs.
Have you already seen our newest product?
Running RT-PCR tests?
Use our Volcano3G® RT-PCR Probe 2x Master Mix: A unique master mix with an engineered, truly thermostable Taq DNA polymerases with reverse transcriptase activity, fast start functionality due to a hotstart aptamer formulation and an already included lysis function for direct RT-PCRs (suitable for SARS-CoV-2/Covid-19 detections). All this for an attractive price. Enter the product page!
*This offer is limited to off-the-shelf products ordered with the special order code. Services, bulk amounts and customizations are excluded. myPOLS Biotec GmbH reserves the right to end this promotion at any time. Offers cannot be combined with other discounts or promotions. Expires November 30, 2020.
News published October 14, 2020
A study in collaboration with the local University of Konstanz, research group of Prof. Hauck, has been published and can now be found on the medRxiv pre-print server: https://www.medrxiv.org/content/10.1101/2020.05.19.20103150v1
As shown in the study, Volcano3G® master mix can be used to reliably detect SARS-CoV2 in extracted samples using the CDC-approved N1 and RNaseP qPCR-assay. When using an additional, high-melting reverse transcription primer, Volcano3G master mix even displayed lower Ct values than other commercially available RT-PCR mixes.
Since RNA extraction is time consuming and the availability of the extraction kits is scarce due to the world wide demand, we additionally explored to detect SARS-CoV2 directly from raw, dry oral swabs. These swabs are simply rinsed with RNase-free water and the sample is then directly added to the RT-PCR reaction. With this setup, samples of patients with a medium to high viral load were accurately detected in agreement with the results of extracted RNA samples. Due to inhibitory effect of the raw sample on the reaction, however, the input of the diluted sample is too low to achieve a reliable detection of SARS-CoV2 in patients with mild symptoms (and hence low viral titers).
We are currently exploring ways to improve the sensitivity of this approach and to launch it as an official, approved diagnostic kit as soon as possible.
myPOLS is upscaling Volcano3G® productions significantly in order to supporting the fight against Corona virus.
We are proud to announce that HiDi DNA polymerase and HiDi Taq DNA polymerase are becoming gold-standard enzymes for mutation detections as recent publications in high-impact journals demonstrate. Please see below
H. Matsunari et al., describing genome edited clones and allele-specific PCR with HiDi DNA polymerase - Link to the scientific publication
M. Serif et al., describing TALEN-mediated gene knockouts and identification by HiDi DNA polymerase - Link to the scientific publication
T. Sakurai et al., describing a CRISP-Cas9 induced mutation identification method - Link to the scientific publication
Ramon (our CEO) was giving a talk at the qPCR conference in Freising this spring. His talk was recorded and is now online available - have a look! (passwort protected video stream (psw is: GQ2019)
After months of tedious work we are proud to announce that our Quality Management system has been certified according to the ISO-Norm 13485:2016 (more details can be found here)
We have successfully established a Direct from Blood Genotyping PCR mix!
Our "DirectBlood Genotyping PCR Mix" allows real-time PCR based genotyping without any previous DNA isolation, directly from blood samples!
Currently we are further developing specific SNP typing assays. They will be launched under research-use only as soon as possible. If you are interested, please provide us with the rs-number of the SNP your are interested in, to receive an individual quotation.